Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Glenmark
Pharma
Lilly, Pfizer-Sciwind, Astellas—Fierce Pharma Asia
Lilly made a trio of investments in East Asia. Pfizer partner Sciwind got an obesity nod in China. MFN appears to have helped Astellas in Japan.
Angus Liu
Mar 13, 2026 8:05am
Glenmark gains FDA nod for first 'true' generic of GSK's Flovent
Mar 5, 2026 12:40pm
Celltrion buy, Rexulti CRL, Glenmark-Hengrui—Fierce Pharma Asia
Sep 26, 2025 10:00am
Glenmark, Hengrui ink $1.1B deal for HER2 ADC
Sep 24, 2025 10:16am
J&J-Fujifilm, drug recalls, RemeGen-Santen—Fierce Pharma Asia
Aug 22, 2025 8:05am
Fierce Biotech
AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer
Jul 10, 2025 9:01am
